Activation of sodium transport in human erythrocytes by beta-adrenoceptor stimulation in vivo
- PMID: 3040390
- DOI: 10.1007/BF00417762
Activation of sodium transport in human erythrocytes by beta-adrenoceptor stimulation in vivo
Abstract
Beta-adrenoceptor stimulation in vivo shifts potassium into the cells. To examine whether human erythrocytes participate in this process, we measured, along with serum or plasma potassium, the concentrations of potassium and sodium in erythrocytes. Beta-adrenoceptor stimulation was obtained by infusion of either fenoterol or hexoprenaline into 6 volunteers at rest or by endogenous amines provoked in 14 volunteers during ergometric exercise. Metabolic effects were followed at rest on serum insulin, C-peptide, and growth hormone levels, and during exercise on pH on lactate concentration in blood. The potassium concentration (mean +/- S.E.M.) dropped (p less than 0.01) in serum from 4.64 +/- 0.37 to 3.19 +/- 0.43 mmol x l-1 in the first hour at rest and in plasma from 5.70 +/- 0.93 to 4.63 +/- 0.45 in 90 sec directly after exercise. The concentration of erythrocyte sodium dropped (p less than 0.001) from 9.68 +/- 0.73 to 8.81 +/- 0.62 mmol x l-1 in cells and from 9.62 +/- 1.16 to 8.55 +/- 1.24 during exercise for 90 s, respectively. Changes in the concentration ratio of cellular sodium to potassium confirmed this sodium shift. An increased sodium transport in erythrocytes due to beta-adrenoceptor stimulation in vivo appears to complement a shift of serum potassium into the cells and may be mediated by the membrane-bound sodium, potassium ATPase.
Similar articles
-
Unsuitability of the human erythrocyte as a model for in vivo sodium transport activation by beta 2 adrenergic agonists.Ann Clin Biochem. 1989 Sep;26 ( Pt 5):444-6. doi: 10.1177/000456328902600511. Ann Clin Biochem. 1989. PMID: 2573312 Clinical Trial.
-
Effect of progressive incremental exercise and beta-adrenergic blockade on erythrocyte ion concentrations.Can J Physiol Pharmacol. 1997 Jan;75(1):19-25. doi: 10.1139/cjpp-75-1-19. Can J Physiol Pharmacol. 1997. PMID: 9101061
-
Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.Eur J Clin Pharmacol. 1996;49(5):341-5. doi: 10.1007/BF00203774. Eur J Clin Pharmacol. 1996. PMID: 8866625 Clinical Trial.
-
Erythrocyte sodium and potassium in patients on peritoneal dialysis.Am J Kidney Dis. 1987 Mar;9(3):211-6. doi: 10.1016/s0272-6386(87)80057-4. Am J Kidney Dis. 1987. PMID: 3826070
-
Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.Thorax. 1996 Jan;51(1):54-8. doi: 10.1136/thx.51.1.54. Thorax. 1996. PMID: 8658370 Free PMC article. Clinical Trial.
Cited by
-
Exercise, training and red blood cell turnover.Sports Med. 1995 Jan;19(1):9-31. doi: 10.2165/00007256-199519010-00002. Sports Med. 1995. PMID: 7740249 Review.
-
Lack of influence of short-term treatment with propranolol and terbutaline on metabolism and energy expenditure of the Na-K pump in human erythrocytes evaluated by microcalorimetry.Eur J Clin Pharmacol. 1993;45(6):571-6. doi: 10.1007/BF00315317. Eur J Clin Pharmacol. 1993. PMID: 8157045 Clinical Trial.